500 related articles for article (PubMed ID: 22936672)
1. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience.
Hart PA; Topazian MD; Witzig TE; Clain JE; Gleeson FC; Klebig RR; Levy MJ; Pearson RK; Petersen BT; Smyrk TC; Sugumar A; Takahashi N; Vege SS; Chari ST
Gut; 2013 Nov; 62(11):1607-15. PubMed ID: 22936672
[TBL] [Abstract][Full Text] [Related]
2. Clinical course of type 1 autoimmune pancreatitis patients without steroid treatment: a Japanese multicenter study of 97 patients.
Kubota K; Kamisawa T; Hirano K; Hirooka Y; Uchida K; Ikeura T; Shiomi H; Ohara H; Shimizu K; Arakura N; Kanno A; Sakagami J; Itoi T; Ito T; Ueki T; Nishino T; Inui K; Mizuno N; Yoshida H; Sugiyama M; Iwasaki E; Irisawa A; Okazaki K; Kawa S; Shimosegawa T; Takeyama Y; Chiba T
J Hepatobiliary Pancreat Sci; 2018 Apr; 25(4):223-230. PubMed ID: 29430861
[TBL] [Abstract][Full Text] [Related]
3. [Relapsing autoimmune pancreatitis type 1: case report].
Ondrejková A; Kianička B; Nechutová H; Hruška L; Novotný I; Souček M
Vnitr Lek; 2017; 63(4):277-283. PubMed ID: 28520452
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in autoimmune pancreatitis: type 1 and type 2.
Kamisawa T; Chari ST; Lerch MM; Kim MH; Gress TM; Shimosegawa T
Gut; 2013 Sep; 62(9):1373-80. PubMed ID: 23749606
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.
Ghazale A; Chari ST; Zhang L; Smyrk TC; Takahashi N; Levy MJ; Topazian MD; Clain JE; Pearson RK; Petersen BT; Vege SS; Lindor K; Farnell MB
Gastroenterology; 2008 Mar; 134(3):706-15. PubMed ID: 18222442
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre.
Besada E; Koldingsnes W; Nossent JC
Rheumatology (Oxford); 2013 Nov; 52(11):2041-7. PubMed ID: 23934313
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.
Alberici F; Smith RM; Jones RB; Roberts DM; Willcocks LC; Chaudhry A; Smith KG; Jayne DR
Rheumatology (Oxford); 2015 Jul; 54(7):1153-60. PubMed ID: 25477054
[TBL] [Abstract][Full Text] [Related]
8. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis.
Sandanayake NS; Church NI; Chapman MH; Johnson GJ; Dhar DK; Amin Z; Deheragoda MG; Novelli M; Winstanley A; Rodriguez-Justo M; Hatfield AR; Pereira SP; Webster GJ
Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1089-96. PubMed ID: 19345283
[TBL] [Abstract][Full Text] [Related]
9. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.
Sellier-Leclerc AL; Baudouin V; Kwon T; Macher MA; Guérin V; Lapillonne H; Deschênes G; Ulinski T
Nephrol Dial Transplant; 2012 Mar; 27(3):1083-9. PubMed ID: 21810762
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
Smith RM; Jones RB; Guerry MJ; Laurino S; Catapano F; Chaudhry A; Smith KG; Jayne DR
Arthritis Rheum; 2012 Nov; 64(11):3760-9. PubMed ID: 22729997
[TBL] [Abstract][Full Text] [Related]
12. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in steroid-responsive pancreatitides (autoimmune pancreatitis).
Sah RP; Chari ST
Curr Opin Gastroenterol; 2015 Sep; 31(5):387-94. PubMed ID: 26154429
[TBL] [Abstract][Full Text] [Related]
14. Risk factors and treatment of relapses in autoimmune pancreatitis: Rituximab is safe and effective.
Soliman H; Vullierme MP; Maire F; Hentic O; Ruszniewski P; Lévy P; Rebours V
United European Gastroenterol J; 2019 Oct; 7(8):1073-1083. PubMed ID: 31662864
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.
Cartin-Ceba R; Golbin JM; Keogh KA; Peikert T; Sánchez-Menéndez M; Ytterberg SR; Fervenza FC; Specks U
Arthritis Rheum; 2012 Nov; 64(11):3770-8. PubMed ID: 22730028
[TBL] [Abstract][Full Text] [Related]
16. Correlation between long-term outcome and steroid therapy in type 1 autoimmune pancreatitis: relapse, malignancy and side effect of steroid.
Shimizu S; Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Kato A; Okumura F; Sano H; Hirata Y; Takada H; Ohara H; Joh T
Scand J Gastroenterol; 2015; 50(11):1411-8. PubMed ID: 26061806
[TBL] [Abstract][Full Text] [Related]
17. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment.
Kim HM; Chung MJ; Chung JB
Pancreas; 2010 Jul; 39(5):555-60. PubMed ID: 20182397
[TBL] [Abstract][Full Text] [Related]
18. Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
Azar L; Springer J; Langford CA; Hoffman GS
Arthritis Rheumatol; 2014 Oct; 66(10):2862-70. PubMed ID: 24943239
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune pancreatitis: current concepts.
Wang Q; Zhang X; Zhang F
Sci China Life Sci; 2013 Mar; 56(3):246-53. PubMed ID: 23526391
[TBL] [Abstract][Full Text] [Related]
20. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]